If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
550.00    30.00 (5.77%)
Bid:
540.00
Ask:
560.00
Spread: 20.00 (3.704%)
Market Cap: £90.23m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Director/PDMR Shareholding

7 Jun 2021 15:58

RNS Number : 0767B
Anpario PLC
07 June 2021
Β 

Β 

Anpario plc("Anpario" or the "Company")

Director/PDMR Shareholding

Anpario announces that it was notified on 4 June 2021 by Peter Lawrence, Non-Executive Chairman, that on 4 June 2021 The Peter Lawrence And Family Charitable Trust sold 11,450 ordinary shares of 23p each in the Company ("Ordinary Shares") at a price of 610p each. Following the disposal, Peter Lawrence and his family have no remaining interest in the issued share capital of the Company.

Enquiries:

Β 

Β 

Β 

Β 

Β 

Anpario plc

Β 

Β 

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

Β 

Karen Prior, Group Finance Director

+44 (0)1909 537 380

Β 

Β 

Β 

Β 

Peel Hunt LLP (NOMAD)

+44 (0)207 418 8900

Β 

Adrian Trimmings

Β 

Β 

Andrew Clark

Β 

Β 

Will Bell

Β 

Β 

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

Peter Lawrence

2

Reason for the notification

a)

Position/status

Β 

Non-Executive Chairman

b)

Initial notification/Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification codeΒ 

Sale of ordinary shares of 23 pence each in the Company ("Ordinary Shares")

Β 

ISIN GB00B3NWT178

Β 

Β 

b)

Nature of the transaction

Β 

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

610p

11,450

Β 

d)

Aggregated information

Β 

Price(s)

Volume(s)

610p

11,450

Β 

e)

Date of the transaction

Β 

4 June 2021

f)

Place of the transaction

Β 

Β 

London Stock Exchange (XLON), AIM

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKZGGVDNNGMZM
Date   Source Headline
25th Jun 20157:00 amRNSAGM Statement
2nd Jun 20152:49 pmRNSHolding(s) in Company
27th May 20158:38 amRNSDirector/PDMR Shareholding
22nd Apr 20151:52 pmRNSHolding(s) in Company
21st Apr 20157:00 amRNSThe Queen's Award for Enterprise
16th Apr 20158:30 amRNSHolding(s) in Company
24th Mar 20154:24 pmRNSHolding(s) in Company
19th Mar 20154:51 pmRNSBlock Listing Application
18th Mar 20152:35 pmRNSHolding(s) in Company
17th Mar 20153:33 pmRNSIssue of Equity
10th Mar 20151:33 pmRNSDirector/PDMR Shareholding
4th Mar 20157:00 amBUSFinal Results
2nd Feb 20157:00 amRNSTrading Statement
23rd Jan 201510:00 amRNSBlocklisting Interim Review
8th Jan 20154:58 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSAgreement with Probiotics
6th Oct 20143:16 pmRNSTransaction in Own Shares
17th Sep 20144:31 pmRNSTransaction in Own Shares
11th Sep 20144:37 pmRNSDirector/PDMR Shareholding
10th Sep 20147:00 amBUSHalf-yearly Report
28th Aug 20144:20 pmBUSHolding(s) in Company
14th Jul 20143:02 pmRNSBlock Listing Application
14th Jul 20143:00 pmRNSBlock Listing Application
3rd Jul 20149:26 amBUSHolding(s) in Company
30th Jun 201410:55 amBUSHolding(s) in Company
25th Jun 20144:09 pmBUSHolding(s) in Company
24th Jun 20144:20 pmBUSResult of AGM
24th Jun 20143:36 pmBUSHolding(s) in Company
24th Jun 20147:00 amRNSTrading Statement
12th Jun 201412:03 pmBUSHolding(s) in Company
9th Jun 201411:54 amBUSDirector/PDMR Shareholding
5th Jun 201410:03 amBUSIssue of Equity
20th May 20143:12 pmBUSHolding(s) in Company
12th May 20147:00 amBUSAnnual Financial Report
15th Apr 20144:09 pmBUSHolding(s) in Company
9th Apr 20149:48 amBUSHolding(s) in Company
2nd Apr 20147:00 amBUSFinal Results
24th Feb 20147:00 amRNSAppointment of Peel Hunt as Nomad and Broker
3rd Feb 20147:00 amBUSTrading Statement
28th Jan 20147:00 amRNSDirector's Dealings
27th Jan 201412:06 pmBUSIssue of Equity
17th Jan 20145:10 pmBUSDirector/PDMR Shareholding
14th Jan 20144:39 pmBUSHolding(s) in Company
9th Jan 20147:01 amBUSDirector/PDMR Shareholding
9th Jan 20147:00 amRNSTrading in line with expectations
12th Dec 201310:07 amBUSHolding(s) in Company
6th Dec 20137:00 amRNSU.S. Office
28th Nov 20137:00 amRNSHolding(s) in Company
30th Oct 20133:27 pmRNSHolding(s) in Company
17th Oct 201312:45 pmBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.